Schistosomiasis and pregnancy

Currently, schistosomes infect approximately 40 million women of child-bearing age, yet little is known about schistosome-associated morbidity in pregnant women and their offspring. Animal models indicate a deleterious effect of schistosome infection on maternal, fetal and neonatal outcomes. Case reports have documented maternal infection in association with poor birth outcomes, and two observational studies indicate that maternal schistosome infection might be associated with decreased birth weight. Rigorously identifying and quantifying the impact of schistosome infection on pregnancy outcomes with well-designed observational and treatment studies are crucial for improving birth outcomes in schistosome-endemic areas. In addition, studies that address the safety of praziquantel during pregnancy could lead to further adoption of the recent informal recommendation by the World Health Organization to treat schistosome-infected pregnant and lactating women.     

Schistosomiasis control in China

This review on the control of schistosomiasis in China consists of the disease in the past, epidemiology, control programme, control approaches, achievements, problems existed and an appendix: the criteria for control and elimination of schistosomiasis in China.     

Schistosomiasis transmission in Lake Malawi

Schistosomiasis (bilharziasis) transmission due to Schistosoma haematobium has for many years been known to occur along protected shorelines in Lake Malawi, but the recent finding that transmission also can also occur along open shorelines with sandy sediment has had a detrimental effect on tourism to Lake Malawi. The present paper shows that transmission, as evidenced from presence of intermediate hosts, along open shorelines is occurring in the southern part of the Lake. Relatively simple precautions can be taken to ensure minimal risk of attracting schistosome infection, and the schistosomiasis risk should not deter people from visiting and diving in Lake Malawi.     

Pathology of Schistosomiasis mansoni in rabbits

The pathology of schistosomiasis mansoni in rabbits was studied with special consideration to worm burden and duration of infection. Heavy and prolonged infections resulted in severe changes involving the intrahepatic portal vein branches, such as: polypoid endophlebitis, granulomatous endophlebitis and, later on, vascular occlusion and recanalization, vascular ectasia, fibrosis and hyalinization of the endothelial polyps. Living and dead adult worms, rather than the mature eggs, were the main pathogenetic factors. For some time the lesions tend to be limited to the portal vein branches, not extending to the periportal tissues, but, after 8 to 10 months, variable degree of portal, septal and intra-parenchymal fibrosis can be formed. However, both vascular and fibrotic changes in the liver had a focal distribution and therefore did not appear to cause portal hypertension and had no resemblance to the human pathology seen in cases of hepatosplenic schistosomiasis. Pathology of schistosomiasis in rabbits has peculiar aspects, which are worthwhile studying, since the model can be of interest for investigations, especially concerning the immunology and immunopathology of schistosomiasis mansoni.     

Schistosomiasis vaccine:research to development

In this article, Robert Bergquist and Dan Colley deal with the consolidated, international efforts to generate a schistosomiasis vaccine; in particular, they summarize the deliberations of a series of meetings, held in Cairo, Egypt, 21-25 May 1997, with the aim of reviewing the current status of affairs in this respect in order to make recommendations for the future course of schistosomiasis vaccine development.